Windlas Biotech Limited has informed the Exchange that Record date for the purpose of BB is 24-Apr-2026.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited's Board has approved a buyback of up to 4,70,000 equity shares (2.23% of total paid-up capital) at INR 1,000 per share, totaling up to INR 47 crore. The buyback represents 9.80% of the company's aggregate paid-up equity share capital and free reserves based on audited standalone and consolidated financials as of March 31, 2025. The buyback will be conducted via the Tender Offer route, excluding promoters and the promoter group who have indicated they will not participate. The record date for determining eligible shareholders has been fixed as April 24, 2026. Fintellectual Corporate Advisors Private Limited has been appointed as the Manager to the Buyback.
The buyback at INR 1,000 per share (with face value of INR 5) signals strong confidence in the company's value and will provide liquidity to shareholders at a significant premium. The stock may see positive movement as the market reacts to this announcement.